Summit Global Investments - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 96 filers reported holding IRADIMED CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$257
-6.9%
5,7880.0%0.02%
-5.6%
Q2 2023$276
-6.4%
5,788
-22.8%
0.02%
-21.7%
Q1 2023$295
-99.9%
7,500
-31.8%
0.02%
-17.9%
Q3 2021$369,000
+25.1%
11,000
-20.3%
0.03%
-6.7%
Q3 2020$295,000
-56.3%
13,800
-52.6%
0.03%
-61.5%
Q2 2020$675,000
+15.4%
29,100
+6.2%
0.08%
-8.2%
Q1 2020$585,00027,4000.08%
Other shareholders
IRADIMED CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders